FDA Accepts Aricept Patch (Donepezil Transdermal System) NDA for Review - Drugs.com MedNews
Links shared publicly online about this topic.
- 867total visits
FDA Accepts Aricept Patch (Donepezil Transdermal System) NDA for Review - Drugs.com MedNews
View full resource at drugs.com
Tags: Alzheimer's Disease Medication, Drug, FDA, Aricept, Eisai
Most Recently Shared on September 17, 2010 at 1:14 pm By:
FDA Accepts Aricept Patch (Donepezil Transdermal System) NDA for Review: WOODCLIFF LAKE, N.J.--(BUSINESS WIRE... http://bit.ly/9SfEfq #drug
Teikoku Pharma USA Announces FDA Accepts Aricept(R) Patch (Donepezil Transdermal System) NDA For Review
medicalnewstoday.com — “Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA)” View full resource at medicalnewstoday.com
Most Recently Shared on September 21, 2010 at 12:05 pm By:
MNT Drug Approvals Health News
Teikoku Pharma USA Announces FDA Accepts Aricept(R) Patch (Donepezil Transdermal System) NDA For Review http://mnt.to/3K3F #regulatory
FDA Accepts Aricept, Patch (Donepezil Transdermal System) NDA For Review - QualityPoint Technologies
qualitypointtech.net — “Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a new weekly transdermal patch of Aricept,, a leading medication for the treatment of Alzheimer's disease. The company developed the weekly Aricept(r) patch based on a license agreement executed between Teikoku Pharma USA, Inc. and Eisai Co., Ltd. (Eisai) in February 2009. The acceptance of the NDA indic” View full resource at qualitypointtech.net
Most Recently Shared on September 18, 2010 at 8:13 pm By:
FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA For Review: Teikoku Pharma USA, Inc., an internat... http://bit.ly/cojyJC
FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA For Review
medicalnewstoday.com — “Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a” View full resource at medicalnewstoday.com
Most Recently Shared on September 18, 2010 at 2:05 pm By:
FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA For Review http://mnt.to/3JZZ #stress
Advertisement
